BioXcel Therapeutics, Inc. (BTAI)
0.0739
-0.04
(-37.11%)
USD |
NASDAQ |
Sep 04, 16:00
0.0434
-0.03
(-41.27%)
After-Hours: 20:00
BioXcel Therapeutics Shareholders Equity (Quarterly) : -115.46M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -115.46M |
| March 31, 2026 | -105.54M |
| December 31, 2025 | -95.46M |
| September 30, 2025 | -88.92M |
| June 30, 2025 | -107.67M |
| March 31, 2025 | -90.17M |
| December 31, 2024 | -93.10M |
| September 30, 2024 | -85.63M |
| June 30, 2024 | -74.30M |
| March 31, 2024 | -72.36M |
| December 31, 2023 | -56.51M |
| September 30, 2023 | -40.61M |
| June 30, 2023 | 5.864M |
| March 31, 2023 | 53.00M |
| December 31, 2022 | 76.78M |
| September 30, 2022 | 126.99M |
| June 30, 2022 | 164.26M |
| March 31, 2022 | 194.02M |
| December 31, 2021 | 221.67M |
| September 30, 2021 | 245.56M |
| Date | Value |
|---|---|
| June 30, 2021 | 267.41M |
| March 31, 2021 | 186.74M |
| December 31, 2020 | 206.70M |
| September 30, 2020 | 220.94M |
| June 30, 2020 | 53.39M |
| March 31, 2020 | 72.59M |
| December 31, 2019 | 26.90M |
| September 30, 2019 | 34.42M |
| June 30, 2019 | 25.16M |
| March 31, 2019 | 32.37M |
| December 31, 2018 | 38.89M |
| September 30, 2018 | 45.82M |
| June 30, 2018 | 49.82M |
| March 31, 2018 | 52.11M |
| December 31, 2017 | -0.982M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -0.324M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.80M |
| Total Liabilities (Quarterly) | 144.26M |
| Debt to Equity Ratio | -0.9047 |
| Current Ratio | 0.2093 |
| Net Debt Paydown Yield | 0.66% |